TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
BVS

Bioventus Inc

Healthcare · Medical Devices

12.90$ +2.2% vs. previous close Closing price · As of: Sep 18, 2026

Ownership

Ownership Structure

Who owns Bioventus Inc (BVS)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 50.2% of the shares are freely tradable; institutional investors hold 78.3%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 78.3%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 11.7%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 50.2%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 5.5%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 68Mio.

Largest Shareholders

Institutions

Institutions BVS
Name Stake (%) Shares Change (%) Date
Essex Woodlands Health Ventures 19.06 13,021,324 +0.0 06/30/2026
Juniper Investment Co, LLC 10.16 6,939,357 +0.0 06/30/2026
Nantahala Capital Management, LLC 8.96 6,122,403 +1.2 03/31/2026
BlackRock Inc 4.59 3,133,541 +0.3 03/31/2026
Vanguard Capital Management, LLC 2.51 1,714,707 +0.0 03/31/2026
Royce & Associates, LP 2.26 1,541,282 +23.2 03/31/2026
American Century Companies Inc 1.98 1,353,415 +118.4 06/30/2026
Geode Capital Management, LLC 1.71 1,168,247 +4.3 03/31/2026

Funds

Funds BVS
Name Stake (%) Shares Change (%) Date
Avantis US Small Cap Value ETF 2.23 1,522,891 +0.3 08/31/2026
iShares Russell 2000 ETF 1.81 1,234,236 -0.6 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?